Guangzhou General Pharmaceutical Research Institute Co., Ltd.
Guangzhou General Pharmaceutical Research Institute Co., Ltd. (GZPIRI), headquartered in Guangzhou, China, is a leading entity in the pharmaceutical research and development sector. Established in 1992, the institute has made significant strides in advancing drug discovery and development, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. GZPIRI focuses on a diverse range of services, including drug formulation, clinical trials, and regulatory compliance, setting itself apart with its commitment to innovation and quality. The institute has garnered recognition for its contributions to the pharmaceutical industry, positioning itself as a trusted partner for both domestic and international clients. With a strong emphasis on research excellence, GZPIRI continues to play a pivotal role in enhancing healthcare solutions across major operational regions in Asia and beyond.
DitchCarbon Score
How does Guangzhou General Pharmaceutical Research Institute Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangzhou General Pharmaceutical Research Institute Co., Ltd.'s score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangzhou General Pharmaceutical Research Institute Co., Ltd., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Guangzhou General Pharmaceutical Research Institute Co., Ltd. This lack of specific initiatives suggests that the company may be in the early stages of developing its climate strategy or may rely on the broader commitments of its parent company. Given the context of the pharmaceutical industry, it is essential for companies like Guangzhou General Pharmaceutical Research Institute to align with industry standards and best practices in carbon management. This includes potentially adopting science-based targets and participating in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability in their environmental impact. In summary, while specific emissions data and reduction targets are not available for Guangzhou General Pharmaceutical Research Institute Co., Ltd., its affiliation with Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited may provide a framework for future climate commitments and performance improvements.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Guangzhou General Pharmaceutical Research Institute Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
